How Technology Is Reshaping Modern Business: From Operations to Customer Experience 
Federal Agencies Secretly Test Anthropic's AI Despite Trump Administration Ban 
Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions 
Goldman Sachs FICC Revenue Falls 10% Amid Iran War Market Volatility 
Federal Judge Dismisses DOJ Lawsuit Attempting to Block Hawaii's Climate Case Against Oil Giants 
KKR's $820M Investment Fuels Samsung SDS AI Expansion, Sending Group Shares Soaring 
NiSource Signs Long-Term Energy Deals with Alphabet and Amazon to Power Indiana Data Centers 
CSN's Cement Unit Sale Could Exceed $2 Billion as Global Giants Circle 
CATL Stock Hits Record High After Q1 2025 Earnings Surge 
Samsung Races to Deliver Next-Gen HBM4E Memory Samples to Nvidia 
Want to cut your energy bills? Here’s how five experts are doing it 
DEEPX Partners with Hyundai to Power Next-Gen AI Robots Ahead of IPO 
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand 
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push 
TSMC Posts Record Q1 Profit Fueled by AI Chip Demand 
Daikin Industries Stock Surges 14% After Elliott Investment Management Discloses Major Stake 
Japan Opens Arms Export Floodgates: New Policy Draws Global Defense Interest 
SAN FRANCISCO, May 30, 2017 -- Invuity, Inc. (NASDAQ:IVTY), an advanced surgical illumination company focused on minimal access surgery, today announced that company management is scheduled to present at the William Blair 37th Annual Growth Stock Conference on June 13, 2017 at 2:10 p.m. Central Time in Chicago.
A live, listen-only webcast of the presentation may be accessed by visiting the Events & Presentations section of the Company's website at www.invuity.com under Investors & Media. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the Company's website for 30 days following the presentation.
About Invuity®
Invuity, Inc. is a leading medical technology company focused on developing and marketing advanced surgical devices to improve the ability of physicians to perform minimal access surgery through smaller and hidden incisions. The company's proprietary Intelligent Photonics™ technology delivers enhanced visualization which facilitates surgical precision, efficiency and safety. In addition, the company utilizes comprehensive strategic marketing programs to create stronger institutional partnerships. Clinical applications include women’s health, encompassing breast cancer and breast reconstruction surgery, gynecology and thyroid surgery. Additional applications include procedures for electrophysiology, spine, orthopedic, cardiothoracic, and general surgery. Invuity is headquartered in San Francisco, CA. For more information, visit www.invuity.com.
CONTACT: Company Contact: Jim Mackaness Chief Financial Officer Invuity, Inc. 415-655-2129 Investors: Mark Klausner Westwicke Partners 443-213-0501 [email protected]
